𝔖 Bobbio Scriptorium

✦ LIBER ✦

PSY31 Cost-Effectiveness of Tapentadol Prolonged-Release (Pr) Compared to Oxycodone Controlled Release (Cr) in Patients with Chronic Severe Non-Cancer Pain in Ireland

✍ Scribed by M. Obradovic; R. Ikenberg; N. Hertel; H. Liedgens

Book ID: 119309914
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 71 KB
Volume: 14
Category: Article
ISSN: 1098-3015
DOI: 10.1016/j.jval.2011.08.1003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sustained Safety and Efficacy of Once-Da

Sustained Safety and Efficacy of Once-Daily Hydromorphone Extended-Release (OROS® hydromorphone ER) Compared with Twice-Daily Oxycodone Controlled-Release Over 52 Weeks in Patients with Moderate to Severe Chronic Noncancer Pain

✍ Ute Richarz; Sandra Waechter; Rainer Sabatowski; Leszek Szczepanski; Heinrich Bi 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 403 KB

333 SHORT FORM-36 (SF-36) AND EUROQOL-5

333 SHORT FORM-36 (SF-36) AND EUROQOL-5 DIMENSION (EQ-5D) RESULTS FROM RANDOMIZED, DOUBLE-BLIND PHASE 3 STUDIES OF TAPENTADOL PROLONGED RELEASE (PR) IN PATIENTS WITH MODERATE TO SEVERE CHRONIC NOCICEPTIVE AND NEUROPATHIC PAIN

✍ R. Lange; B. Lange; A. Greene; A. Okamoto; M. Etropolski; J. Ashworth 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 265 KB